Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study
Titel:
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study
Auteur:
Rothenberg, M.L. Cox, J.V. Butts, C. Navarro, M. Bang, Y.-J. Goel, R. Gollins, S. Siu, L.L. Laguerre, S. Cunningham, D.